Personalised Therapeutics Group

Our focus is on using emerging stem cell and genomics technologies to develop therapies for patients with Motor Neuron Disease, Parkinson’s disease and Dementia. We believe that patient stem cells (iPSC’s) holds the key to developing new tools to diagnose disease, classify disease sub-types, predict disease severity, and select the most effective therapies for patients.

The Personalised Therapeutics Laboratory has developed novel in vivo models and dual-species transcriptomic profiling techniques to analyse patient stem cells. Our long-term aim is to use these tools to develop personalised therapeutics to provide early intervention and tailored treatments for individual patients.